EQ001 (Itolizumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EQ001 (Itolizumab), covering 2025-04-18 to 2025-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis [Phase 1]